| Hans-Günter Meyer-Thompson | Naltrexon
Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19.
Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19.
Pitt B, Tate AM, Gluck D, Rosenson RS, Goonewardena SN.
Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):402-405. doi: 10.1093/ehjcvp/pvac014. PMID: 35179184; PMCID: PMC8903502.